Nektar Therapeutics | NKTR - Ordinary Share Capital


Nektar Therapeutics reported $29.47M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
ALKERMES USD 167.54M 1.08M Jun/2026
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Amgen USD 541M 1000K Jun/2026
Baxter International USD 517M 549K Jun/2026
BioCryst Pharmaceuticals USD 255.26M 42.2M Jun/2026
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cara Therapeutics USD 9.38M 2.01K Mar/2026
Cipla INR 807.78M 17K Mar/2026
Dr.Reddys Laboratories INR 832.69M 176K Mar/2026
Eisai JPY 282.46M 345K Jun/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Exelixis USD 248.88M 4.82M Jun/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
Grifols EUR 680.58M 846.11K Dec/2025
Halozyme Therapeutics USD 114.04M 4.48M Jun/2026
Incyte USD 200.98M 1.03M Jun/2026
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
Karyopharm Therapeutics USD 22.54M 4.23M Mar/2026
MacroGenics USD 63.56M 241K Mar/2026
Merck USD 2.47B 4.93M Mar/2026
Nektar Therapeutics USD 29.47M 9.09M Mar/2026
Neurocrine Biosciences USD 100.55M 50K Jun/2026
Novartis USD 1.9B 7.38M Jun/2026
Pfizer USD 5.7B 0 Jun/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Sarepta Therapeutics USD 105.62M 53K Jun/2026
Takeda JPY 1.58B 460K Jun/2026
Teva Pharmaceutical Industries USD 1.16B 1000K Jun/2026
Xencor USD 74.33M 265K Jun/2026